RUCAPARIB VS CHEMOTHERAPY IN PATIENTS WITH ADVANCED, RELAPSED OVARIAN CANCER AND A DELETERIOUS BRCA MUTATION: EFFICACY AND SAFETY FROM ARIEL4, A RANDOMIZED PHASE 3 STUDY

R. Kristeleit,A. Lisyanskaya, A. Fedenko,M. Dvorkin,A. C. De Melo,Y. Shparyk, I. Rakhmatullina,I. Bondarenko, N. Colombo, V. Svintsitskiy,L. Biela, M. Nechaeva,F. Raspagliesi,G. Scambia, D. Cibula,R. Poka, A. Oaknin, T. Safra, B. Mackowiak-Matejczyk,L. Ma

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER(2021)

引用 3|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要